Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-18 · accession 0001193125-25-288529 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-11-19 | 2025-11-18+ | TYRA | Bensen Daniel | COO | S - Sale | $16.17 | -125.6K | 220.9K | -36% | -$2.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-19 | S | D | 49,956 | $16.32 | 170,981 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.04 to $16.68. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2025-11-18 | S | D | 75,633 | $16.07 | 220,937 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.24. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |